The phrase "analytical models do" is correct and usable in written English.
It can be used when discussing the functions or actions performed by analytical models in various contexts, such as research, data analysis, or decision-making.
Example: "In our study, we found that analytical models do provide significant insights into consumer behavior."
Alternatives: "analytical models perform" or "analytical models accomplish".
Therefore, current analytical models do not capture the effects of soil saturation on the uplift resistance of buried pipeline.
Conventionally, these analytical models do not account for the complex loading and reacting conditions of umbrella arch support systems throughout the tunnel excavation and support sequence.
While these models have made great strides in EA framework evaluation, the intuitive models lack a structured framework and the analytical models do not capture intuitive preferences of multiple DMs.
This sampling of configurational phase space introduces a probabilistic aspect to the cooling process which the analytical model does not incorporate.
At operating conditions relevant to practical RO applications, film theory and the numerical model accurately predicted channel-averaged experimental permeate flux and salt rejection data, while the more recent analytical model did not.
Mackey: Yes, the analytical model does not do well with multiple causes and multiple effects and interactions and interdependence, and feedback loops.
However, the analytical model does not provide information about the effects of P. vitreus on wood tissue, e.g. the distribution of degraded pits.
This divergence could be explained by the fact that the analytical model does not take into consideration the second-order effects, such as the ISI introduced by the Gaussian filter employed by the GFSK modulator.
Also, the fact that the cold sphere CRC at the end converged to the same value than that of the hot sphere having the same diameter (see Appendix 2) proved that the background activity is well reproduced and that the analytical model does not underestimate or overestimate the scatter contribution.
Despite this limitation, these survey measures were previously validated in a study of colorectal cancer screening and our analytical model did include objective measures of clinical and demographic characteristics.
In addition, the linear decision analytical model did not permit a statistical analysis of the cost differences between sunitinib and bevacizumab plus IFN nor did it permit an analysis of the effect of adverse events on treatment efficacy; additional studies may be needed to confirm these data.
